US · Healthcare · Healthcare Plans
EPS came in at 0.17 against a street estimate of 0.13 — a beat of 30.8%.
Analysts rate Alignment Healthcare LLC a buy (7 buy, 3 hold, 1 sell out of 11) with an average price target of $24.62.
| Fund | Stake |
|---|---|
| Wellington Management Company LLP | 8.24% |
| FMR Inc | 7.66% |
| BlackRock Inc | 6.79% |
| T. Rowe Price Investment Management,Inc. | 6.34% |
| Vanguard Portfolio Management, LLC | 4.68% |
| Vanguard Capital Management, LLC | 3.84% |
| Amvescap Plc. | 3.37% |
| Hood River Capital Management LLC | 2.92% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-30 |
| Results announced · Q3 2026 | 2026-07-30 |
| Shareholder vote results · Q2 2026 | 2026-06-09 |
| Charter / bylaws change · Q2 2026 | 2026-05-12 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-04-24 |
| Annual report FY2025 | 2026-02-27 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alignment Healthcare LLC — free to start.
Google PlayApp StoreData updated 2026-08-05.